Operating

Change in Inventories

Year-over-year, this metric declined by 117.5%, from $152.30M to -$26.60M. Over 4 years (FY 2021 to FY 2025), Change in Inventories shows a downward trend with a -13.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026

How to read this metric

An increase might signal preparation for a major product launch or, conversely, slowing demand and potential future write-downs.

Detailed definition

This metric tracks the change in the value of raw materials, work-in-progress, and finished goods held by the company. A...

Peer comparison

Consumer hardware companies aim for high inventory turnover to minimize the risk of product obsolescence.

Metric ID: change_in_inventories

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$31.30M$109.10M$163.70M$88.60M$240.10M$223.50M$144.30M$46.80M$100.40M$77.20M$47.30M$155.80M$181.80M$164.40M$117.70M$152.30M$42.50M$82.60M$0.00-$26.60M
QoQ Change+448.6%+50.0%-45.9%+171.0%-6.9%-35.4%-67.6%+114.5%-23.1%-38.7%+229.4%+16.7%-9.6%-28.4%+29.4%-72.1%+94.4%-100.0%
YoY Change+867.1%+104.9%-11.9%-47.2%-58.2%-65.5%-67.2%+232.9%+81.1%+113.0%+148.8%-2.2%-76.6%-49.8%-100.0%-117.5%
Range-$31.30M$240.10M
CAGR-3.4%
Avg YoY Growth+59.5%
Median YoY Growth-29.5%
Current Streak2 quarters decline

Frequently Asked Questions

What is Regeneron Pharmaceuticals's change in inventories?
Regeneron Pharmaceuticals (REGN) reported change in inventories of -$26.60M in Q1 2026.
How has Regeneron Pharmaceuticals's change in inventories changed year-over-year?
Regeneron Pharmaceuticals's change in inventories decreased by 117.5% year-over-year, from $152.30M to -$26.60M.
What is the long-term trend for Regeneron Pharmaceuticals's change in inventories?
Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's change in inventories has grown at a -13.4% compound annual growth rate (CAGR), from $494.30M to $277.40M.
What does change in inventories mean?
The change in the value of products and materials the company has in stock.